STEMLINE THERAPEUTICS INC

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$14.0M

269 transactions

Summary

STEMLINE THERAPEUTICS INC is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $128KSales: $13.5M14 insiders

Date	Insider	Type	Value
2020-06-10	ZUERBLIS KENNETH J	D	—
2020-06-10	ZUERBLIS KENNETH J	D	—
2020-06-10	ZUERBLIS KENNETH J	U	—
2020-06-10	Forman Alan S	D	—
2020-06-10	Forman Alan S	D	—
2020-06-10	Forman Alan S	U	—
2020-06-10	Cline Darren S	U	—
2020-06-10	Francomano Robert(Chief Commercial Officer)	D	—
2020-06-10	Francomano Robert(Chief Commercial Officer)	U	—
2020-06-10	Hoberman Kenneth(Chief Operating Officer)	D	—
2020-06-10	Hoberman Kenneth(Chief Operating Officer)	D	—
2020-06-10	Hoberman Kenneth(Chief Operating Officer)	A	$0
2020-06-10	Hoberman Kenneth(Chief Operating Officer)	U	—
2020-06-10	BENTSUR RON	D	—
2020-06-10	BENTSUR RON	D	—
2020-06-10	BENTSUR RON	D	—
2020-06-10	BENTSUR RON	D	—
2020-06-10	BENTSUR RON	U	—
2020-06-10	Bergstein Ivan(Chief Executive Officer)	D	—
2020-06-10	Bergstein Ivan(Chief Executive Officer)	D	—

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

STEMLINE THERAPEUTICS INC — Contributions, Lobbying & Contracts | Poliscope